Flash Mob Study With Regard to Travel Willingness Among Patients With Cancer
Flashmobstudie Landelijke Meting Reisbereidheid Medisch Oncologische Zorg
1 other identifier
observational
5,000
1 country
1
Brief Summary
This is a cross-sectional study in the form of a flash mob study, in which an inventory will be made on 13 and 14 March 2023 of the willingness to travel of oncology patients in the participating hospitals. Patients who have an appointment with an internist-oncologist or oncology specialist nurse at the outpatient clinic or by telephone and patients who come to day treatment unit for medical oncology are asked to participate. Willingness to travel is examined by means of a survey, in which a minimal set of categorized patient data (e.g. age, gender, level of education) is collected as part of the survey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2023
CompletedFirst Submitted
Initial submission to the registry
March 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedJuly 11, 2023
July 1, 2023
2 months
March 20, 2023
July 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Travel willingness
How far is the oncological patient willing to travel for his/her systemic treatment or follow-up?
1 day
Secondary Outcomes (2)
Facilitating and inhibiting factors for willingness to travel
1 day
Which patient characteristics are associated with willingness to travel?
1 day
Study Arms (1)
Cohort: medical oncology patients in the out-patient clinic or treatment unit on 13 or 14 march 2023
No interventions.
Interventions
No intervention. Willingness to travel is examined through a survey. The survey will be conducted digitally, but may also be done on paper. In the survey a minimal set of categorized patient data (e.g. age, gender, level of education) is collected as part of the survey. For patients who cannot independently complete the questionnaire (for example due to low literacy skills), a volunteer, medical student or researcher is allowed to help the patient.
Eligibility Criteria
Medical Oncology patients who have an (call) appointment with our medical oncology outpatient clinic and/or day treatment unit on 13 or 14 march 2023.
You may qualify if:
- Medical oncology patients with an appointment in the out-patient clinic or day treatment unit on 13 or 14 march 2023
- Medical oncology patients with an (video) call appointment in the out-patient clinic on 13 or 14 march 2023
You may not qualify if:
- Patients in the inpatients oncology unit
- Medical oncology patients with no appointment on 13 or 14 march 2023
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Groningen
Groningen, 9713 GZ, Netherlands
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
An KL Reyners, MD, PhD
University Medical Center Groningen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2023
First Posted
July 11, 2023
Study Start
March 13, 2023
Primary Completion
May 1, 2023
Study Completion
May 1, 2023
Last Updated
July 11, 2023
Record last verified: 2023-07